Bologna
Italy
29
2016-09-08
19
2017-08-08
These are the the leading inventors for applications assigned to ALFA WASSERMANN, S.P.A.:
ALFA WASSERMANN, S.P.A. based in Bologna, IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Rifaximin derivative and uses thereof
#2 | 2015-12-03 ✅ Patent 9,364,467 granted on 2016-06-14Rifaximin derivative and uses thereof
#3 | 2015-10-22 ✅ Patent 9,359,357 granted on 2016-06-07Forms of rifaximin and uses thereof
#4 | 2014-07-03GASTRORESISTANT PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN
#5 | 2014-04-24 ✅ Patent 10,285,944 granted on 2019-05-14Gastroresistant pharmaceutical formulations containing rifaximin
#6 | 2013-11-21 ✅ Patent 8,741,904 granted on 2014-06-03Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
#7 | 2013-10-31 ✅ Patent 8,853,231 granted on 2014-10-07Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
#8 | 2013-07-18MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FORMULATIONS
#9 | 2013-03-21 ✅ Patent 8,748,449 granted on 2014-06-10Use of polyols to obtain stable polymorphous forms of rifaximin
#10 | 2012-10-11RIFAXIMIN COMPOSITIONS AND METHOD OF USE
#11 | 2012-09-27 ✅ Patent 8,518,949 granted on 2013-08-27Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
#12 | 2012-09-27PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE
#13 | 2012-08-23PROCESSES FOR THE PRODUCTION OF POLYMORPHIC FORMS OF RIFAXIMIN
#14 | 2012-08-09POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN
#15 | 2012-08-09PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN
#16 | 2012-04-12MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FROMULATIONS
#17 | 2012-03-08 ✅ Patent 8,404,704 granted on 2013-03-26Use of polymorphic forms of rifaximin for medical preparations
#18 | 2012-02-09RIFAXIMIN COMPOSITIONS AND METHOD OF USE
#19 | 2011-06-30 ✅ Patent 8,173,801 granted on 2012-05-08Processes for the production of polymorphic forms of rifaximin
#20 | 2011-06-30 ✅ Patent 8,158,781 granted on 2012-04-17Polymorphic forms α, β and γ of rifaximin
#21 | 2011-06-23 ✅ Patent 8,158,644 granted on 2012-04-17Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
#22 | 2011-04-14RIFAXIMIN COMPOSITIONS AND METHOD OF USE
#23 | 2010-01-14 ✅ Patent 8,217,054 granted on 2012-07-10Use of polyols to obtain stable polymorphous forms of rifaximin
#24 | 2009-09-17 ✅ Patent 7,612,199 granted on 2009-11-03Polymorphic forms α, β, and γ of rifaximin
#25 | 2009-05-21 ✅ Patent 8,193,196 granted on 2012-06-05Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
#26 | 2008-10-23 ✅ Patent 7,923,553 granted on 2011-04-12Processes for the production of polymorphic forms of rifaximin
#27 | 2008-10-23 ✅ Patent 7,902,206 granted on 2011-03-08Polymorphic forms α, β and γ of rifaximin
#28 | 2008-10-23 ✅ Patent 7,906,542 granted on 2011-03-15Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
#29 | 2008-06-05 ✅ Patent 7,915,275 granted on 2011-03-29Use of polymorphic forms of rifaximin for medical preparations
Also check out Alfa Wassermann, S.p.A.'s (Bologna, Italy) applicant profile with 6 patent applications submitted.
15037 ⎘